Cardinal Health Inc(CAH)
USD --+0.00%
Reward51Moderate
Risk43Moderate
📊75%Data
Thin 1% profit margin · Revenue growing 19% YoY
CAH
+0.0 · +0.00%
USD · NYSE
Cardinal Health Inc | Healthcare
Balanced
Market Cap:47.73Bn
ℹ️
Reward Rating
51
Moderate
Bottom 50% (model universe)
75% data coverage
ℹ️
Risk Rating
43
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on CAH to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

Analyst Target

Analyst consensus price target: $248.27.

What is Cardinal Health Inc?

operates as a healthcare services and products company in the United States and internationally.

CAH · Verdict

Moderate reward · moderate risk

CAH's standout is volatility, while profitability remains the main concern.

Based on 88% data coverage

CAH · Verdict

What’s working & what to watch

Strengths 1

  • Volatility65/100

    Above average

Watchouts 1

  • Profitability39/100

    1% net margin · 0% ROE

Model-based scoring. For information only — not financial advice.

What is Cardinal Health Inc?

operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company is listed on the NYSE in USA, operating in the Healthcare sector, with a market capitalisation of 47.73B, and a P/E ratio of 29.1x.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue and earnings growing steadily, indicating improving operating performance.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Risk profile appears balanced versus broad market conditions.
💸 Valuation
Valuation appears fair relative to current fundamentals.

OpenBook Logo Analysis

Reward: Moderate (51)

The scoring profile indicates limited reward potential at this time, with growth and valuation offering the most support. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap47.73B
P/E Ratio29.1408
Dividend Yield0.99%
52 Week High233.0351
52 Week Low136.6289
Last AnnualJune
IPO Date12/31/1987
IncorporatedUSA
Shares Outstanding235M
No. of Employees53,084
IndustryMedical Distribution
ExchangeNYSE
Beta0.65
CurrencyUSD